Invention Grant
- Patent Title: Expanded NK cells
- Patent Title (中): 扩大的NK细胞
-
Application No.: US14830758Application Date: 2015-08-20
-
Publication No.: US09585914B2Publication Date: 2017-03-07
- Inventor: Sirac Dilber , Evren Alici
- Applicant: Cellprotect Nordic Pharmaceuticals AB
- Applicant Address: SE Stockholm
- Assignee: CELLPROTECT NORDIC PHARMACEUTICALS AB
- Current Assignee: CELLPROTECT NORDIC PHARMACEUTICALS AB
- Current Assignee Address: SE Stockholm
- Agency: Bergenstråhle & Partners AB
- Agent Gabriela B. Tomescu
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K35/12 ; C12N5/0783 ; A61K39/00
Abstract:
The present invention relates to expanded NK cells. The NK cells have been expanded ex vivo, are activated and have a cytotoxic phenotype. The cytotoxicity against malignant cells is markedly increased compared to non-expanded NK cells. The invention also relates to a method of treatment.
Public/Granted literature
- US20150374754A1 EXPANDED NK CELLS Public/Granted day:2015-12-31
Information query
IPC分类:
